Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Ranpak Holdings
PACK
$439M
| $65K | ﹤0.01% |
+12,400
| New | +$78.8K |
|
3602
Owlet
OWLT
$149M
| $64K | ﹤0.01% |
14,064
+8,878
| +171% | +$52.6K |
|
3603
Farmmi Inc
FAMI
$6.33M
| $63K | ﹤0.01% |
1,456
-328
| -18% | -$19.7K |
|
3604
Lipocine
LPCN
$17.5M
| $63K | ﹤0.01% |
11,668
+121
| +1% | +$935 |
|
|
PPTA
3605
Perpetua Resources
PPTA
$2.3B
| $63K | ﹤0.01% |
14,100
-43,114
| -75% | -$149K |
|
|
TKLF
3606
Yoshitsu Co
TKLF
$8.34M
| $63K | ﹤0.01% |
6,471
+1,417
| +28% | +$16.8K |
|
|
TMQ
3607
Trilogy Metals
TMQ
$541M
| $63K | ﹤0.01% |
118,500
-36,258
| -23% | -$21.4K |
|
3608
Five Point Holdings
FPH
$373M
| $62K | ﹤0.01% |
+26,305
| New | +$61.6K |
|
3609
Inuvo
INUV
$15.1M
| $62K | ﹤0.01% |
21,320
+2,500
| +13% | +$8.76K |
|
3610
Surrozen
SRZN
$258M
| $62K | ﹤0.01% |
6,820
+5,047
| +285% | +$61.5K |
|
3611
Catheter Precision
VTAK
$906K
| $62K | ﹤0.01% |
+212
| New | +$115K |
|
|
NAVB
3612
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $62K | ﹤0.01% |
238,133
+172,800
| +264% | +$50.5K |
|
3613
DSS Inc
DSS
$5.39M
| $61K | ﹤0.01% |
15,394
+1,982
| +15% | +$8.34K |
|
3614
Tempest Therapeutics
TPST
$13.7M
| $61K | ﹤0.01% |
2,038
+84
| +4% | +$1.84K |
|
|
THRN
3615
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $61K | ﹤0.01% |
13,100
+300
| +2% | +$1.32K |
|
|
CNTA
3616
DELISTED
Centessa Pharmaceuticals
CNTA
| $60K | ﹤0.01% |
+15,700
| New | +$57.4K |
|
|
MYSE
3617
Myseum.AI Inc
MYSE
$11M
| $60K | ﹤0.01% |
10,570
-14,100
| -57% | -$84.6K |
|
|
VSTA
3618
DELISTED
Vasta Platform
VSTA
| $60K | ﹤0.01% |
18,900
+400
| +2% | +$1.56K |
|
3619
Xilio Therapeutics
XLO
$59.9M
| $60K | ﹤0.01% |
1,343
-1,307
| -49% | -$57.4K |
|
|
BEST
3620
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $60K | ﹤0.01% |
19,000
+50
| +0.3% | +$147 |
|
|
VNTR
3621
DELISTED
Venator Materials PLC
VNTR
| $60K | ﹤0.01% |
147,738
-219,100
| -60% | -$120K |
|
3622
Mind CTI
MNDO
$19.4M
| $59K | ﹤0.01% |
29,800
-8,700
| -23% | -$19.6K |
|
3623
INNOVATE Corp
VATE
$111M
| $59K | ﹤0.01% |
+1,990
| New | +$58.1K |
|
3624
Aurora
AUR
$12.6B
| $58K | ﹤0.01% |
41,800
-10,600
| -20% | -$15.7K |
|
|
CPAC
3625
Cementos Pacasmayo
CPAC
$1.01B
| $58K | ﹤0.01% |
+10,900
| New | +$57.7K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.